Cargando…

Kidney failure and the federal government /

Overview -- Summary -- Introduction -- Patients and providers -- Perspectives of ESRD patients -- Ethical issues -- The patient population -- The ESRD patient population: special groups -- Structure of the provider community -- Access -- Access problems of ESRD patients -- Access to kidney transplan...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Committee for the Study of the Medicare End-Stage Renal Disease Program
Otros Autores: Rettig, Richard A., Levinsky, Norman G. (Norman George), 1929-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academy Press, 1991.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • ""Kidney Failure and the Federal Government""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""PART I Overview""; ""Summary""; ""THE CONGRESSIONAL CHARGE TO THE INSTITUTE OF MEDICINE""; ""BASIC ASSUMPTIONS""; ""ESRD PATIENTS AND THEIR TREATMENT""; ""ACCESS""; ""ETHICS""; ""THE PROVIDER COMMUNITY""; ""REIMBURSEMENT AND QUALITY""; ""Reimbursement Effects on Quality""; ""Outpatient Dialysis Reimbursement Issues""; ""Covered Services""; ""Rate-Setting and Payment Policy""; ""QUALITY ASSESSMENT AND ASSURANCE""; ""DATA SYSTEMS""; ""RESEARCH""; ""NOTES""; ""REFERENCES""; ""1 Introduction""
  • ""THE CONGRESSIONAL CHARGE""""BASIC ASSUMPTIONS""; ""CONTEXT OF THIS STUDY""; ""STUDY METHODS""; ""THE ESRD PATIENT POPULATION""; ""NATIONAL EXPENDITURES FOR ESRD""; ""ORGANIZATION OF THE REPORT""; ""NOTES""; ""REFERENCES""; ""PART II Patients and Providers""; ""2 Perspectives of ESRD Patients""; ""EXPERIENCES WITH RENAL FAILURE""; ""Patient Relationships with Physicians and Staff""; ""Patient Education""; ""Patient-Related Services""; ""Effect of Erythropoietin""; ""ECONOMIC EFFECTS OF KIDNEY FAILURE""; ""CONCLUSIONS""; ""NOTE""; ""REFERENCE""; ""3 Ethical Issues""
  • ""PATIENT ACCEPTANCE CRITERIA""""WITHDRAWAL FROM TREATMENT""; ""Guidelines""; ""Advance Directives""; ""TREATING THE PROBLEM PATIENT""; ""CONCLUSIONS AND RECOMMENDATIONS.""; ""NOTES""; ""REFERENCES""; ""4 The Patient Population""; ""INCIDENCE AND PREVALENCE""; ""COMPOSITION OF THE ESRD POPULATION""; ""MORTALITY ISSUES""; ""Unadjusted Mortality""; ""Adjusted Mortality""; ""Subgroup Mortality""; ""STATE AND REGIONAL MORTALITY DATA""; ""CROSS-NATIONAL MORTALITY DATA""; ""PROJECTIONS TO THE YEAR 20006""; ""NOTES""; ""REFERENCES""; ""5 The ESRD Patient Population: Special Groups""
  • ""PEDIATRIC PATIENTS""""ELDERLY ESRD PATIENTS""; ""DIABETIC PATIENTS""; ""HYPERTENSIVE PATIENTS""; ""Hypertension in the United States""; ""Relationship Between Hypertension and Hypertensive ESRD""; ""Epidemiology of ESRD Attributed to Hypertension""; ""Intervention""; ""MINORITY PATIENTS""; ""CONCLUSION""; ""NOTES""; ""REFERENCES""; ""6 Structure of the Provider Community""; ""OVERVIEW""; ""Outpatient Dialysis Facilities""; ""Kidney Transplant Centers""; ""Pediatric Facilities""; ""CHANGING STRUCTURE OF THE OUTPATIENT DIALYSIS COMMUNITY""; ""Hospital-Based Versus Independent Providers9""
  • ""Hospital-Based Providers""""Patients""; ""Independent Providers""; ""Outpatient Dialysis Facilities""; ""Not-For-Profit Versus For-Profit Providers11""; ""Not-For-Profit Providers""; ""For-Profit Providers""; ""Size of Outpatient Dialysis Facilities12""; ""Facility Ownership""; ""CONCLUSIONS""; ""NOTES""; ""REFERENCES""; ""PART III Access""; ""7 Access Problems of ESRD Patients""; ""ESRD PATIENTS NOT ELIGIBLE FOR MEDICARE""; ""Who Are the Reported Noneligibles?""; ""Magnitude of the Problem""; ""Geographic Variations""; ""Payment Sources""; ""State Medicaid Programs""